2. Effective Date. This Assignment shall become effective on the date (the “Effective
Date”) all of the following conditions have been satisfied: (a) all of the Settling Parties have
executed this Assignment; and (b) either (i) at least $7.5 million in insurance proceeds have been
paid out from those Policies listed under “Tower 3 (E&O)” in Schedule II or (ii) the Medley D&Os
have executed a release of the insurance companies that issued the Policies listed under “Tower 3
(E&O)” in Schedule II in connection with those insurance companies’ funding some or all of a
settlement of the Pre-April 30 Claims.
3. Expiration Date. If the Effective Date does not occur prior to July 1, 2023, this
Assignment becomes null and void, and neither this Assignment nor evidence of its terms shall be
admissible for any purpose in any action or proceeding.7
"
-------------------------------------------------------------------
All posts are strictly my opinion and are not buy or sell recommendations.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM